Last reviewed · How we verify
Cyclobenzaprine hydrochloride 2%
Cyclobenzaprine hydrochloride 2% is a Muscle relaxant (centrally acting) Small molecule drug developed by Express Specialty Pharmacy. It is currently in Phase 2 development for Acute musculoskeletal pain and muscle spasms (topical formulation in Phase 2). Also known as: Cyclobenzaprine hydrochloride.
Cyclobenzaprine is a centrally acting muscle relaxant that reduces muscle tension by depressing activity in the brainstem.
Cyclobenzaprine is a centrally acting muscle relaxant that reduces muscle tension by depressing activity in the brainstem. Used for Acute musculoskeletal pain and muscle spasms (topical formulation in Phase 2).
At a glance
| Generic name | Cyclobenzaprine hydrochloride 2% |
|---|---|
| Also known as | Cyclobenzaprine hydrochloride |
| Sponsor | Express Specialty Pharmacy |
| Drug class | Muscle relaxant (centrally acting) |
| Modality | Small molecule |
| Therapeutic area | Musculoskeletal/Pain Management |
| Phase | Phase 2 |
Mechanism of action
Cyclobenzaprine works primarily through central nervous system depression, acting on the brainstem to reduce motor neuron activity and muscle tone. It is structurally related to tricyclic antidepressants and may have some noradrenergic activity. The drug is used to relieve muscle spasms associated with acute musculoskeletal conditions.
Approved indications
- Acute musculoskeletal pain and muscle spasms (topical formulation in Phase 2)
Common side effects
- Drowsiness
- Dizziness
- Dry mouth
- Fatigue
- Headache
Key clinical trials
- A Single-Dose, Randomized, Open-Label, 2-Way Crossover Study to Evaluate the Dose-Proportionality, Safety, and Tolerability of TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) in Healthy Japanese and Chinese Subjects (PHASE1)
- Comparing Adjuvant Treatments for High Tone Pelvic Floor Dysfunction (PHASE2, PHASE3)
- Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- Multimodal Analgesia Effect on Post Surgical Patient (PHASE4)
- Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL) (PHASE2)
- A Comparative Study of EMG Biofeedback and Pharmacotherapy for the Treatment of Masticatory Muscle Hyperactivity in Bruxism Patients (NA)
- 12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients (PHASE3)
- A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cyclobenzaprine hydrochloride 2% CI brief — competitive landscape report
- Cyclobenzaprine hydrochloride 2% updates RSS · CI watch RSS
- Express Specialty Pharmacy portfolio CI
Frequently asked questions about Cyclobenzaprine hydrochloride 2%
What is Cyclobenzaprine hydrochloride 2%?
How does Cyclobenzaprine hydrochloride 2% work?
What is Cyclobenzaprine hydrochloride 2% used for?
Who makes Cyclobenzaprine hydrochloride 2%?
Is Cyclobenzaprine hydrochloride 2% also known as anything else?
What drug class is Cyclobenzaprine hydrochloride 2% in?
What development phase is Cyclobenzaprine hydrochloride 2% in?
What are the side effects of Cyclobenzaprine hydrochloride 2%?
Related
- Drug class: All Muscle relaxant (centrally acting) drugs
- Manufacturer: Express Specialty Pharmacy — full pipeline
- Therapeutic area: All drugs in Musculoskeletal/Pain Management
- Indication: Drugs for Acute musculoskeletal pain and muscle spasms (topical formulation in Phase 2)
- Also known as: Cyclobenzaprine hydrochloride
- Compare: Cyclobenzaprine hydrochloride 2% vs similar drugs
- Pricing: Cyclobenzaprine hydrochloride 2% cost, discount & access